SCHEMBL3170458

SCHEMBL3170458

CC(C)(C)OC(=O)ON1CCC(Oc2ncnc(Nc3ccc(S(C)(=O)=O)nc3)c2[N+](=O)[O-])CC1

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 20/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3164118 0.91 GPR119 (0.70) GPR119
SCHEMBL391654 0.89 GPR119 (0.64) GPR119
SCHEMBL3162133 0.87 GPR119 (0.54) GPR119
SCHEMBL3155420 0.86 GPR119 (0.68) GPR119
SCHEMBL3164762 0.85 GPR119 (0.53) GPR119
SCHEMBL3167392 0.82 GPR119 (0.72) GPR119
SCHEMBL3163892 0.80 GPR119 (0.61) GPR119
SCHEMBL3170380 0.80 GPR119 (0.59) GPR119
SCHEMBL3165926 0.80 GPR119 (0.61) GPR119
SCHEMBL389108 0.80 GPR119 (0.77) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644357-B9 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2010-03-24 EP claimed
EP-1644357-B1 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2007-12-12 EP claimed